Neurofibroma, Plexiform - 25 Studies Found
Active, not recruiting |
: Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 (16 Years +) :
|
Completed |
: Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas :
: Drug: RAD001: Everolimus 10 mg of RAD001 will be self-administered orally once daily continuously for on |
Completed |
: Study of Plexiform Neurofibromas in Neurofibromatosis Type 1 :
: 2000-11-03 |
Recruiting |
: PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) :
|
Completed |
: Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas :
: 2011-01-11 : Drug: Tasigna Following enrollment each subject will initially receive Tasigna orally at 200 mg twice da |
Terminated |
: Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma :
: 2003-05-06 :
|
Completed |
: Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas :
: 2003-02-05 : Drug: pirfenidone |
Completed |
: Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas :
: 2002-02-14 :
|
Completed |
: Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development : Cancer : 2006-06-19 |
Active, not recruiting |
: AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine :
: Drug: Cediranib Maleate Other Names: |